GeneralBreaking NewsBreakingLatest News
Supreme Court Criticizes Centre for Hospitals' Excessive Pricing
Sentiment: NegativeHigh Priority
What Happened?
The Supreme Court has criticized the Indian government for the high margins charged by hospitals on medicines, calling it 'loot' and 'dacoity'. The court questioned why the pricing system favors manufacturers over patients.
Key points
- The Supreme Court questioned the disparity between the maximum retail price (MRP) and the price to retailers.
- The court criticized the government's reluctance to regulate medicine prices effectively.
- Hospitals were described as charging excessive margins, impacting vulnerable patients.
- A case was highlighted where a chemotherapy injection cost ₹1,30,000 at a hospital but only ₹11,000 to dealers.
- The court reserved its verdict on a public interest litigation seeking price regulation and trade margin caps.
Key insights
- The Supreme Court's decision could lead to stricter regulations on medicine pricing.
- Patients may benefit from mandatory prescriptions for generic medicines.
- The case raises awareness about the financial burden of healthcare on patients.
Why it matters
The court's remarks highlight the need for better regulation of medicine prices to protect patients from excessive healthcare costs.
Source
Times Now
